short term moving back above 21 is likely. apparently i think market will become more volatile as the Dec 16 interest rate decision approaches, which will definitely affect XBI and LABU, even though interest rate shouldn't affect biotech.
I would have sold this at 21.5ish if I wasn't so greedy this morning but I was thinking it would raise to 22 (my sell order) since the market was roaring. looks like i was wrong and bought more in the low 20s.
Market Data 
Markets 
AI
